DV
Dividend Vision

ANAB — AnaptysBio, Inc.

AnaptysBio, Inc. (ANAB)

Total return is 415.9% over the past 9.5 years, 122.8 points ahead of SPY at 293.1%. Its deepest 1-year drawdown was 28.0%.

ANAB is an equity stock that does not function as a traditional ETF—it is a single publicly traded company rather than a diversified fund holding multiple underlying assets. The security pays no dividend distributions, making it unsuitable for income-focused investors seeking regular dividend payments. This holding appeals primarily to growth-oriented investors seeking exposure to the biotechnology sector rather than those targeting dividend yield.

ANAB key facts

Asset type
Stock
Asset class
Equity
Inception date
01/26/2017
Distribution frequency
None
Last close
$58.47
Market cap
$1,731,207,808
Average volume
330900.0
Beta
0.403
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.06